Efficacy and Safety Evaluations of Anlotinib in Patients with Advanced Non-small Cell Lung Cancer Treated with Bevacizumab

被引：0
|
作者：
Jiang, F. [1 ]
Li, J. [1 ]
Kong, X. [1 ]
Qu, H. [1 ]
Sun, P. [1 ]
机构：
[1] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Yantai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Anlotinib; Non-small cell lung cancer (NSCLC); Bevacizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-07
引用
收藏
页码：S436 / S436
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Han, B.
    Chu, T.
    Zhong, R.
    Zhong, H.
    Zhang, B.
    Zhang, W.
    Shi, C.
    Qian, J.
    Han, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S129 - S129
  • [32] Salvage treatment with anlotinib for advanced non-small cell lung cancer
    Wu, Di
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Han, Jindi
    Han, Sen
    Long, Jieran
    Wang, Yang
    Zhang, Ziran
    Fang, Jian
    [J]. THORACIC CANCER, 2019, 10 (07) : 1590 - 1596
  • [33] A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer.
    Wang, Jinlin
    Yi, Tienan
    Dong, Youhong
    Xu, Xinhua
    Cao, Fengjun
    Ran, Ruizhi
    Yin, Yifa
    Li, Yinping
    Fu, Yang
    Xu, Yanhua
    Kuang, Li
    Chen, Guiming
    Qu, Guangqiao
    Li, Jun
    Luo, Zhiguo
    Chen, Yuan
    Song, Qibin
    Chu, Qian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China
    Chen, Xin-Zu
    [J]. JAMA ONCOLOGY, 2019, 5 (01) : 116 - 117
  • [35] Association of the bevacizumab pharmacokinetics with efficacy and toxicity in advanced non-small cell lung cancer
    Inaba, Megumi
    Saeki, Sho
    Sasaki, Jiichiro
    Sakata, Shinya
    Sato, Ryo
    Saruwatari, Koichi
    Kishi, Hiroto
    Fujii, Shinji
    Hamada, Akinobu
    Kohrogi, Hirotsugu
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 77 - 77
  • [36] Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small Cell Lung Cancer
    Wu, Feng Ying
    Zhang, Shi Jia
    Ren, Sheng Xiang
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1286 - S1287
  • [37] Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program
    Govindan, Ramaswamy
    Natale, Ronald
    Wade, James
    Herbst, Roy
    Krebs, Annetta
    Reiling, Richard
    Hensing, Thomas
    Wozniak, Antoinette
    Belani, Chandra P.
    Kelly, Karen
    Ochs, Judith
    [J]. LUNG CANCER, 2006, 53 (03) : 331 - 337
  • [38] Efficacy and Safety of Rhus verniciflua Stokes Extracts in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
    Cheon, Seong Ha
    Kim, Kyung Seok
    Kim, Sehyun
    Jung, Hyun Sik
    Choi, Won Cheol
    Eo, Wan Kyu
    [J]. FORSCHENDE KOMPLEMENTARMEDIZIN, 2011, 18 (02): : 77 - 83
  • [39] Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
    Wang, Z.
    Han, X.
    Guo, J.
    Zhu, D.
    Zhang, X.
    Tang, X.
    Meng, X.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1400 - S1400
  • [40] The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease
    Ryoko Shimizu
    Daichi Fujimoto
    Ryoji Kato
    Takehiro Otoshi
    Takahisa Kawamura
    Koji Tamai
    Takeshi Matsumoto
    Kazuma Nagata
    Kyoko Otsuka
    Atsushi Nakagawa
    Kojiro Otsuka
    Nobuyuki Katakami
    Keisuke Tomii
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 1159 - 1166
12345